Abstract
Background: Implantable cardioverter/defibrillator (ICD) treatment has reduced the mortality of patients with a high risk of sudden cardiac death. However, ICD discharges may cause anxiety with respect to new discharges and lead to preventive, for example, phobic, behavior. This study evaluated the frequency of panic disorders and agoraphobia in patients with ICD and assessed the risk factors in their development.
Hypothesis: Treatment with ICD represents a risk factor in the development of anxiety disorders.
Methods: Ninety patients with ICD were examined using a standardized lifetime Diagnostic Interview of Psychiatric Syndromes (DIPS). This interview makes it possible to estimate the incidence of panic disorders and agoraphobia. The impact of the severity of the underlying cardiac disease, the number of ICD discharges, and the subjective appraisal of the shock experience on the development of panic disorders and agoraphobia was assessed.
Results: Fifteen patients (16.7%) developed anxiety disorders after ICD implantation. The incidence was 21% in patients with and 6.9% in patients without ICD discharge. In patients with two or more ICD discharges annually, the incidence of panic disorders and agoraphobia was higher than that in patients with a single ICD discharge annually (62 vs. 10%, p < 0.01). The intensity of self‐observation of their body was significantly related to the development of anxiety disorders (p < 0.001).
Conclusion: Panic disorders and agoraphobia are frequent side effects of ICD treatment. Risk factors in the development of these disorders are two or more ICD discharges annually and a negative cognitive appraisal of ICD discharges. Therapeutic efforts should aim at reducing the number of ICD discharges and provide early psychological treatment.
Keywords: ventricular tachyarrhythmia, implantable cardioverter/defibrillator, panic disorder, agoraphobia
Full Text
The Full Text of this article is available as a PDF (43.3 KB).
References
- 1. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death. Structure, function, and time‐dependence of risk. Circulation 1992; 85 (1 suppl): I2–10 [PubMed] [Google Scholar]
- 2. Kuck KH, Cappato R, Siebels J, Rüppel R: Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748–754 [DOI] [PubMed] [Google Scholar]
- 3. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B: Canadian Implantable Defibrillator Study (CIDS)—a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 21: 1297–1302 [DOI] [PubMed] [Google Scholar]
- 4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators : A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near‐fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576–1583 [DOI] [PubMed] [Google Scholar]
- 5. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown, MW , Heo M: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933–1940 [DOI] [PubMed] [Google Scholar]
- 6. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G: A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999; 341: 1882–1890 [DOI] [PubMed] [Google Scholar]
- 7. Lüderitz B, Jung W, Deister A, Marneros A, Manz M: Lebensqualität nach Implantation eines Kardioverters / Defibrillators bei malignen Herzrhythmusstörungen. Dtsch Med Wochenschr 1993; 118: 285–289 [DOI] [PubMed] [Google Scholar]
- 8. Chevalier P, Verrier P, Kirkorian G, Touboul P, Cottraux J: Improved appraisal of quality of life in patients with automatic implantable cardioverter defibrillator: A psychometric study. Psychother Psychosom 1996; 65: 49–56 [DOI] [PubMed] [Google Scholar]
- 9. Morris PL, Badger J, Chmielewski C, Berger E, Goldberg RJ: Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator. Psychosomatics 1991; 32: 58–64 [DOI] [PubMed] [Google Scholar]
- 10. Schöhl W, Trappe HJ, Lichtlen PR: Acceptance and quality of life after implantation of an automatic cardioverter / defibrillator. Z Kardiol 1994; 83: 927–932 [PubMed] [Google Scholar]
- 11. Keren R, Aarons D, Veltri EP: Anxiety and depression in patients with life‐threatening ventricular arrhythmias: Impact of the implantable cardioverter‐defibrillator. Pacing Clin Electrophysiol 1991; 14: 181–187 [DOI] [PubMed] [Google Scholar]
- 12. Pauli P, Wiedemann G, Dengler W, Blaumann‐Benninghoff G, Kuhlkamp V: Anxiety in patients with an automatic implantable cardioverter defibrillator: What differentiates them from panic patients? Psychosom Med 1999; 61: 69–76 [DOI] [PubMed] [Google Scholar]
- 13. Spielberger CD: State‐Trait‐Anger‐Expression‐Inventory. Palo Alto, Calif.: Consulting Psychologist Press, 1988. [Google Scholar]
- 14. Bourke JP, Turkington D, Thomas G, McComb JM, Tynan M: Florid psychopathology in patients receiving shocks from implanted cardioverter‐defibrillators. Heart 1997; 78: 581–583 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Margraf J: Diagnostic Interview of Psychiatric Disease (DIPS). Berlin: Springer, 1994. [Google Scholar]
- 16. American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders (3rd edition ‐ revised). Washington, DC: American Psychiatric Association, 1987. [Google Scholar]
- 17. Eaton WW, Anthony JC, Romanski A, Tien A, Gallo J, Cai G, Neufeld K, Schlaepfer T, Laugharne J, Chen LS: Onset and recovery from panic disorder in the Baltimore Epidemiologic Catchment Area follow‐up. Br J Psychiatry 1998; 173: 501–507 [DOI] [PubMed] [Google Scholar]
- 18. Herrmann C, von zur Muhen F, Schaumann A, Buss U, Kemper S, Wantzen C, Gonska BD: Standardized assessment of psychological well‐being and quality‐of‐life in patients with implanted defibrillators. Pacing Clin Electrophysiol 1997; 20: 95–103 [DOI] [PubMed] [Google Scholar]
- 19. Mackintosh NJ: Conditioning and Associative Learning. Oxford: Oxford University Press, 1983. [Google Scholar]
- 20. Eysenck, HJ : The conditioning model of neurosis. Behav Brain Sci 1979; 2: 155–199 [Google Scholar]
- 21. Mowrer OH: Learning Theory and Behavior. New York: J. Wiley, 1960. [Google Scholar]
- 22. Ahmad T, Wardle J, Hayward P: Physical symptoms and illness attribution in agoraphobia and panic. Behav Res Ther 1992; 30: 493–500 [DOI] [PubMed] [Google Scholar]
- 23. Clark DM: A cognitive model of panic attacks In Panic: Psychological Perspectives (Eds. Rachman S, Maser JD.). New Jersey: Lawrence Erlbaum Associates, 1988. [Google Scholar]
- 24. Ehlers A, Margraf J, Roth WT, Taylor CB, Maddock RJ, Sheikh J, Kopell ML, McClenahan KL, Gossard D, Blowers GH: Lactate infusions and panic attacks: Do patients and controls respond differently? Psychiatry Res 1986; 17: 295–308 [DOI] [PubMed] [Google Scholar]
- 25. Rapee RM, Brown TA, Antony MM, Borlow DH: Response to hyperventilation and inhalation of 5.5% carbon dioxide‐enriched air across the DSM‐III‐R anxiety disorders. J Abnorm Psychol 1992; 101: 538–552 [DOI] [PubMed] [Google Scholar]
- 26. Vlay SC, Olson LC, Fricchione GL, Friedman R: Anxiety and anger in patients with ventricular tachyarrhythmias. Responses after automatic internal cardioverter‐defibrillator implantation. Pacing Clin Electrophysiol 1989; 12: 366–373 [DOI] [PubMed] [Google Scholar]
- 27. Chambles DL, Goldstein A: The treatment of agoraphobia In Handbook of Behavioral Interventions (Eds. Goldstein A, Foa EB.). New York: J. Wiley, 1980. [Google Scholar]
- 28. Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowky EN: Prevention of implantable‐defibrillator shocks by treatment with sotalol. D,1‐Sotalol Implantable Cardioverter‐Defibrillator Study Group. N Engl J Med 1999; 340: 1855–1862 [DOI] [PubMed] [Google Scholar]
- 29. Ost LG, Westling BE: Applied relaxation vs. cognitive behaviour therapy in the treatment of panic disorder. Behav Res Ther 1995; 33: 145–158 [DOI] [PubMed] [Google Scholar]
- 30. Bakker A, van Dyck R, Spinhoven P, van Balkom AJ: Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. J Clin Psychiatry 1999; 60: 831–838 [DOI] [PubMed] [Google Scholar]